Aaron Wealth Advisors LLC cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 65.4% during the 1st quarter, Holdings Channel reports. The institutional investor owned 3,882 shares of the medical research company’s stock after selling 7,330 shares during the quarter. Aaron Wealth Advisors LLC’s holdings in Agilent Technologies were worth $442,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in A. SHP Wealth Management acquired a new position in shares of Agilent Technologies during the fourth quarter worth $26,000. Core Wealth Advisors LLC acquired a new stake in Agilent Technologies in the fourth quarter valued at $26,000. Board of the Pension Protection Fund acquired a new position in shares of Agilent Technologies in the fourth quarter worth approximately $27,000. Navalign LLC acquired a new position in shares of Agilent Technologies in the 4th quarter worth approximately $27,000. Finally, MV Capital Management Inc. acquired a new position in shares of Agilent Technologies in the 4th quarter worth approximately $28,000.
Agilent Technologies News Summary
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent completed its acquisition of Biocare Medical, strengthening its diagnostics and clinical pathology offerings and potentially improving long-term growth prospects. Agilent finalizes Biocare Medical takeover
- Positive Sentiment: Sanford C. Bernstein initiated coverage with an outperform rating and a $155 price target, which may bolster investor confidence in additional share price upside. Benzinga coverage
- Positive Sentiment: Recent commentary highlights Agilent’s post-earnings resilience, reflecting steady investor interest after the company beat expectations and raised/confirmed guidance. Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
- Neutral Sentiment: Piper Sandler initiated coverage at Neutral with a $150 target, which is supportive but less bullish than Bernstein’s call. Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
- Neutral Sentiment: Articles about dividend reliability and broader adoption of Agilent software suggest steady fundamentals, but they are less likely to drive a major near-term stock move. Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? Shanghai ICRD Adopts Agilent Software
- Neutral Sentiment: Agilent’s stock has been trading with modest strength following the earnings release, but the move appears tied more to execution and sentiment than to any single dramatic catalyst. Agilent (A) stock trades up, here is why
Agilent Technologies Price Performance
Agilent Technologies (NYSE:A – Get Free Report) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the firm posted $1.31 earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.
Agilent Technologies Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s payout ratio is currently 20.48%.
Analysts Set New Price Targets
Several research firms have recently weighed in on A. Royal Bank Of Canada started coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective for the company. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Barclays raised their target price on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 24th. Wells Fargo & Company lowered their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Finally, Robert W. Baird boosted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $160.88.
Check Out Our Latest Stock Report on A
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Read More
- Five stocks we like better than Agilent Technologies
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
